Related Experiment Video
Updated: Jul 6, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Mitigate Japan's Drug Loss With Model-Informed Drug Development
Yasuhiko Imai1, Emi Akatsu1, Suzanne K Minton2
1Certara GK, Tokyo, Japan.
Drug loss in Japan, where approved medicines aren't available locally, can be reduced. A strategic approach using Model-Informed Drug Development (MIDD) with AI/ML can improve patient access to vital treatments.
Area of Science:
- Pharmaceutical Sciences
- Drug Development
- Regulatory Science
Background:
- 'Drug loss' in Japan describes approved drugs lacking local development or approval.
- This phenomenon limits patient access to potentially beneficial therapies.
Purpose of the Study:
- To explore strategies for minimizing 'drug loss' in Japan.
- To highlight the role of Model-Informed Drug Development (MIDD) and AI/ML in addressing this issue.
Main Methods:
- Reviewing current drug development and approval processes in Japan.
- Analyzing the potential of MIDD strategies, augmented by artificial intelligence/machine learning (AI/ML).
Main Results:
- A comprehensive MIDD strategy, enhanced with AI/ML, can significantly reduce instances of 'drug loss'.
- This approach streamlines development and approval pathways.
Conclusions:
- Implementing advanced MIDD with AI/ML is crucial for minimizing 'drug loss' in Japan.
- Sustained collaboration between the pharmaceutical industry and regulatory bodies is essential for patient access and global advancement.
Related Concept Videos
Drug Discovery: Overview
Drug Regulation
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Drug Clearance: Overview
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...

